Skip to main content

CVS Health’s stock jumps as it overhauls prescription-drug pricing

CVS Health shares climbed as the drug-store chain set 2024 revenue guidance that tops analyst expectations and announced a revamp of its prescription-drug pricing model.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.